Topoisomerase II trapping agent teniposide induces apoptosis and G2/M or S phase arrest of oral squamous cell carcinoma

World Journal of Surgical Oncology

Volumn 4, Issue , 2006, Pages

  Li, Jinzhong ^a   Chen, Wantao ^a   Zhang, Ping ^a   Li, Ningyi ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DNA TOPOISOMERASE (ATP HYDROLYSING); TENIPOSIDE;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG EFFICACY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MOUTH CARCINOMA; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TRANSMISSION ELECTRON MICROSCOPY;

EID: 33747333594     PISSN: 14777819     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-4-41     Document Type: Article

References (21)

1. Qiu WL: Progress and achievements in diagnosis, treatment and research of oral tumors: 10-year review. Chinese Arch Otolaryngol Head Neck Surg 1996, 3:57-61.
2. Morse-Gaudio M, Risley MS: Topoisomerase II expression and VM-26 induction of DNA breaks during spermatogenesis in Xenopus Laevis. J Cell Sci 1994, 107:2887-2898.
3. Andreassen PR, Lacroix FB, Margolis RL: Chromosomes with two intact axial cores are induced by G2 checkpoint override: evidence that DNA decatenation is not required to template the chromosome structure. J Cell Biol 1997, 136:29-43.
4. Mo YY, Beck WT: DNA damage signals induction of Fas ligand in tumor cells. Mol Pharmacol 1999, 55:216-222.
5. Heck MM, Earnshaw WC: Topoisomerase II, a specific marker for cell proliferation. J Cell Biol 1986, 103:2569-2581.
6. Liu LF: DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 1989, 58:351-375.
7. Bruden DA, Osheroff N: Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim Biophys Acta 1998, 1400:139-154.
8. Bepler G, O'Briant K: In vitro chemosensitivity testing of human non-small cell lung cancer cell lines, Anticancer Res 1998, 18(5A):3181-3185.
9. Van der Gaast A, Splinter TA: Teniposide (VM-26) in ovarian cancer: a review. Semin Oncol 1992, 19(2 Suppl 6):95-97.
10. Nielsen D, Boas J, Engelholm SA, Hansen OP, Dombernowsky P: VM-26 in advanced breast cancer. A phase II trial in patients with no prior chemotherapy. Ann Oncol 1992, 3:377-378.
11. Woessner RD, Mattern MR, Mirabelli CK, Johnson RK, Drake FH: Proliferation dependent and cell cycle-dependent differences in expression of the 170-kilodalton and 180-kilodalton forms of topoisomerase-II in NIH 3T3 cells. Cell Growth Differ 1991, 2:209-214.
12. Nakopoulou L, Lazaris AC, Kavantzas N, Alexandrou P, Athanassiadou P, Keramopoulos A, Davaris P: DNA topoisomerase II-alpha immunoreactivity as a marker of tumor aggressiveness in invasive breast cancer. Pathobiology 2000, 68(3):137-143.
13. Willman JH, Holden JA: Immunohist Chemical staining for DNA topoisomerase II alpha in benign, premalignant, and malignant lesions of the prostate. Prostate 2000, 42:280-286.
14. Stathopoulos GP, Kapranos N, Manolopoulos L, Papadimitriou C, Adamopoulos G: Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck. Anticancer Res 2000, 20:177-182.
15. Sabourin M, Osheroff N: Sensitivity of human type II topoisomerases to DNA damage: stimulation of enzyme-mediated DNA cleavage by a basic, oxidized and alkylated lesions. Nucleic Acids Res 2000, 28:1947-1954.
16. Chen W, Zhou X. Xu Q, Guo W, Lin L: Chemosensitivity testing of oral cancer with biopsy specimens. Zhonghua Kau Qiang Yi Xue Za Zhi 2002, 37:404-407.
17. Fountzilas G, Lim LO, Yunis AA: The inhibitory effects of teniposide and homoharringtonine on the growth of pancreatic carcinoma cells in vitro. Anticancer Res 1988, 8:343-346.
18. Rao PN: The molecular basis of drug-induced G2 arrest inmammalian cells. Mol Cell Biochem 1980, 29:47-57.
19. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science 1989, 246:629-634.
20. Murray WA: Creative blocks: cell-cycle checkpoints and feedback controls. Nature 1992, 359:599-604.
21. Chen M, Beck WT: Differences in inhibition of chromosome separation and G2 arrest by DNA topoisomerase II inhibitors Merbarone and VM-26. Cancer Res 1995, 55:1509-1516.